LivaNova Third-Quarter 2026 GAAP Diluted EPS Drops 78% to $0.11

PUBT · 1d ago
LivaNova Third-Quarter 2026 GAAP Diluted EPS Drops 78% to $0.11
  • LivaNova’s third-quarter 2026 GAAP diluted earnings per share fell 78% year over year to $0.11.
  • Revenue rose 10% year over year to $393.1 million, with growth across all regions in Cardiopulmonary and Neuromodulation.
  • A new oxygenator manufacturing line achieved operational production, expanding capacity to address strong customer demand.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Livanova plc published the original content used to generate this news brief via Business Wire (Ref. ID: 20261104266833) on November 04, 2026, and is solely responsible for the information contained therein.